Retraction Note: Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma
1 Laboratory of NFκB Signalling, Institute of Molecular and Cell Biology (IMCB), Agency for Science Technology and Research (A*STAR), Singapore, Republic of Singapore.
2 Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
3 Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.
4 Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea.
5 Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
6 Laboratory of Translational Biomedical Proteomics, Institute of Molecular and Cell Biology (IMCB), Agency for Science Technology and Research (A*STAR), Singapore, Republic of Singapore.
7 Department of Neurosurgery, Samsung Medical Center, Seoul, Republic of Korea.
8 Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. taojiang1964@163.com.
9 Beijing Tiantan Hospital, Capital Medical University, Beijing, China. taojiang1964@163.com.
10 Laboratory of NFκB Signalling, Institute of Molecular and Cell Biology (IMCB), Agency for Science Technology and Research (A*STAR), Singapore, Republic of Singapore. vinayt@imcb.a-star.edu.sg.
11 Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Republic of Singapore. vinayt@imcb.a-star.edu.sg.
12 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Republic of Singapore. vinayt@imcb.a-star.edu.sg.